Table 4. HbA1c among diabetic patients on CSII versus MD regimen by their gender.

P: Independent samples t-test; *P<0.05 (significant); HbA1c: hemoglobin A1c; MDI: multiple daily injections; CSII: continuous subcutaneous insulin infusion.

HbA1c	Male				p-value	Female				p-value
	MDI		CSII			MDI		CSII
	Mean	SD	Mean	SD		Mean	SD	Mean	SD
HbA1c outside the diabetic center	9.7	1.8	8.9	1.7	0.148	9.5	2.5	8.8	2.8	0.189
HbA1c inside the diabetic center	9.3	1.8	8.7	2.0	0.340	9.2	2.0	8.7	1.7	0.285
HbA1c after three months of follow-up in the diabetic center	8.5	1.8	8.3	1.9	0.744	8.6	1.8	7.9	1.5	0.084
HbA1c after six months of follow-up in the diabetic center	9.0	1.7	8.5	1.6	0.379	8.8	1.6	8.1	1.5	0.041*
HbA1c after nine months of follow-up in the diabetic center	9.1	1.6	8.3	1.2	0.120	9.0	1.6	7.9	1.3	0.001*